Regeneron Pharmaceuticals
REGN
#230
Rank
NZ$174.10 B
Marketcap
NZ$1,683
Share price
-0.19%
Change (1 day)
27.70%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2026 (TTM): NZ$82.56

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ$85.88. In 2025 the company made an earnings per share (EPS) of NZ$78.82 an increase over its 2024 EPS that were of NZ$74.73.

EPS history for Regeneron Pharmaceuticals from 2010 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$82.564.74%
2025NZ$78.825.48%
2024NZ$74.7310.34%
2023NZ$67.73-8.56%
2022NZ$74.07-47%
2021NZ$139.75133.36%
2020NZ$59.8969.13%
2019NZ$35.41-14.44%
2018NZ$41.39100.71%
2017NZ$20.6231.78%
2016NZ$15.6538.96%
2015NZ$11.2672.55%
2014NZ$6.53-17.55%
2013NZ$7.92-44.98%
2012NZ$14.39
2010NZ-$2.32

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.21-85.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$9.60-88.83%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
NZ$31.77-63.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.62-95.78%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$4.31-94.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$36.21-57.83%๐Ÿ‡บ๐Ÿ‡ธ USA